Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice
Authors:
Open Access
- 11 March 2009
- journal article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 12 (08) , 1055-1065
Abstract
The serotonin syndrome is a potential side-effect of serotonin-enhancing drugs, including antidepressants such as selective serotonin reuptake inhibitKeywords
This publication has 86 references indexed in Scilit:
- Imaging Elevated Brain Arachidonic Acid Signaling in Unanesthetized Serotonin Transporter (5-HTT)-Deficient MiceNeuropsychopharmacology, 2009
- Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims dataBritish Journal of Clinical Pharmacology, 2008
- Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient micePsychopharmacology, 2008
- Serotonin Syndrome and Rhabdomyolysis Induced by Concomitant Use of Triptans, Fluoxetine and HypericumCephalalgia, 2007
- Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive DisorderThe American Journal of Human Genetics, 2006
- Interaction of Serotonergic Antidepressants and Opioid Analgesics: Is Serotonin Syndrome Going Undetected?Journal of the American Medical Directors Association, 2005
- Tramadol reduces the 5-HTP-induced head–twitch response in mice via the activation of μ and κ opioid receptorsLife Sciences, 2002
- The Efficacy of Intramuscular Tramadol as a Rapid-Onset AntidepressantAustralian & New Zealand Journal of Psychiatry, 2000
- The Pharmacology of TramadolDrugs, 1994
- An animal behavior model for studying central serotonergic synapsesLife Sciences, 1976